Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Significant Decline in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 4,300 shares, a decline of 97.2% from the November 30th total of 154,900 shares. Based on an average daily trading volume, of 721,100 shares, the days-to-cover ratio is presently 0.0 days.

Reckitt Benckiser Group Stock Up 0.7 %

Shares of OTCMKTS:RBGLY traded up $0.08 during trading on Friday, reaching $12.13. The company’s stock had a trading volume of 312,350 shares, compared to its average volume of 844,703. The firm’s 50 day simple moving average is $12.31 and its two-hundred day simple moving average is $11.78. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $15.03.

Analyst Ratings Changes

Several research firms recently weighed in on RBGLY. Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th. Barclays raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. Finally, Citigroup upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and four have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Get Our Latest Stock Report on RBGLY

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.